Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction

• Main Authors: Danyelle M. Liddle, Amber L. Hutchinson, Hannah R. Wellings, Krista A. Power, Lindsay E. Robinson, Jennifer M. Monk
• Format: Article
• Language: English
• Published: MDPI AG 2017-11-01
• Series: Nutrients
• Subjects: n-3 polyunsaturated fatty acids; obesity; adipose tissue; immune cell infiltration; inflammation; adipokines; T cells; macrophages
• Online Access: https://www.mdpi.com/2072-6643/9/12/1289

Obesity is a global health concern with rising prevalence that increases the risk of developing other chronic diseases. A causal link connecting overnutrition, the development of obesity and obesity-associated co-morbidities is visceral adipose tissue (AT) dysfunction, characterized by changes in the cellularity of various immune cell populations, altered production of inflammatory adipokines that sustain a chronic state of low-grade inflammation and, ultimately, dysregulated AT metabolic function. Therefore, dietary intervention strategies aimed to halt the progression of obese AT dysfunction through any of the aforementioned processes represent an important active area of research. In this connection, fish oil-derived dietary long-chain n-3 polyunsaturated fatty acids (PUFA) in the form of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been demonstrated to attenuate obese AT dysfunction through multiple mechanisms, ultimately affecting AT immune cellularity and function, adipokine production, and metabolic signaling pathways, all of which will be discussed herein.